Code of Federal Regulations · Subpart
Subpart G — Specific Labeling Requirements For Specific Drug Products
21 C.F.R. pt. 201, subpt. G
- § 201.300 Notice To Manufacturers, Packers, And Distributors Of Glandular Preparations
- § 201.301 Notice To Manufacturers, Packers, And Distributors Of Estrogenic Hormone Preparations
- § 201.302 Notice To Manufacturers, Packers, And Distributors Of Drugs For Internal Use Which Contain Mineral Oil
- § 201.303 Labeling Of Drug Preparations Containing Significant Proportions Of Wintergreen Oil
- § 201.304 Tannic Acid And Barium Enema Preparations
- § 201.305 Isoproterenol Inhalation Preparations (pressurized Aerosols, Nebulizers, Powders) For Human Use; Warnings
- § 201.306 Potassium Salt Preparations Intended For Oral Ingestion By Man
- § 201.307 Sodium Phosphates; Package Size Limitation, Warnings, And Directions For Over-the-counter Sale
- § 201.308 Ipecac Syrup; Warnings And Directions For Use For Over-the-counter Sale
- § 201.309 Acetophenetidin (phenacetin)-containing Preparations; Necessary Warning Statement
- § 201.310 Phenindione; Labeling Of Drug Preparations Intended For Use By Man
- § 201.311 [reserved]
- § 201.312 Magnesium Sulfate Heptahydrate; Label Declaration On Drug Products
- § 201.313 Estradiol Labeling
- § 201.314 Labeling Of Drug Preparations Containing Salicylates
- § 201.315 Over-the-counter Drugs For Minor Sore Throats; Suggested Warning
- § 201.316 Drugs With Thyroid Hormone Activity For Human Use; Required Warning
- § 201.317 Digitalis And Related Cardiotonic Drugs For Human Use In Oral Dosage Forms; Required Warning
- § 201.319 Water-soluble Gums, Hydrophilic Gums, And Hydrophilic Mucilloids (including, But Not Limited To Agar, Alginic Acid, Calcium Polycarbophil, Carboxymethylcellulose Sodium, Carrageenan, Chondrus, Glucomannan ((b-1,4 Linked) Polymannose Acetate), Guar Gum, Karaya Gum, Kelp, Methylcellulose, Plantago Seed (psyllium), Polycarbophil Tragacanth, And Xanthan Gum) As Active Ingredients; Required Warnings And Directions
- § 201.320 Warning Statements For Drug Products Containing Or Manufactured With Chlorofluorocarbons Or Other Ozone-depleting Substances
- § 201.323 Aluminum In Large And Small Volume Parenterals Used In Total Parenteral Nutrition
- § 201.325 Over-the-counter Drugs For Vaginal Contraceptive And Spermicide Use Containing Nonoxynol 9 As The Active Ingredient; Required Warnings And Labeling Information
- § 201.326 Over-the-counter Drug Products Containing Internal Analgesic/antipyretic Active Ingredients; Required Warnings And Other Labeling
- § 201.327 Over-the-counter Sunscreen Drug Products; Required Labeling Based On Effectiveness Testing
- § 201.328 Labeling Of Medical Gas Containers